Flagship explainer
What drives SUPERNUS PHARMACEUTICALS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$38.5M | FY2025 |
| |
| Income before tax | −$49M | FY2025 |
|
| Operating income | −$62.3M | FY2025 |
|
| $719M | FY2025 |
| |
| Ending assets | $1.5B | FY2025 |
|
| Beginning assets | $1.4B | FY2024 |
|
| $1.1B | FY2025 |
| |
| $1.0B | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001356576-26-000011